// App-Quantinova.ai

MON-1051 : Cardiovascular Safety of DPP-4 Inhibition in Patients with Type 2 Diabetes Mellitus: Endothelial Progenitor Cells As an Early Marker of Long-Term Cardiovascular Risk

Researchers

Presenter

  • Wan Aizad Wan Mahmood

Principal Investigators

  • Thomas King

  • Tommy Kyaw Tun

  • Seamus K Sreenan

  • John McDermott

Medical Centers

  • Connolly Hospital, Dublin, Ireland

  • Connolly Hospital, Dublin, Ireland

Locations

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Type 2 diabetes mellitus

  • Coronary Artery Disease

  • Diabetes

Biomarkers

  • Creatinine

  • Hemoglobin A1c

  • Body mass index

  • Endothelial progenitor cells

Drug/Treatment

  • saxagliptin

  • Adianor

  • Metformin Hydrochloride

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved